Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1

被引:120
作者
Matsushita, Arikira
Gotze, Tobias
Korc, Murray
机构
[1] Dartmouth Coll, Hitchcock Med Ctr, Dept Med, Lebanon, NH 03756 USA
[2] Dartmouth Coll, Hitchcock Med Ctr, Dept Pharmacol, Lebanon, NH 03756 USA
[3] Dartmouth Coll, Hitchcock Med Ctr, Dept Toxicol, Lebanon, NH 03756 USA
[4] Dartmouth Coll, Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
[5] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA
关键词
D O I
10.1158/0008-5472.CAN-07-3256
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuropilin-1 (Np-1), a receptor for semaphorin 3A and vascular endothelial growth factor, is expressed at high levels in pancreatic ductal adenocarcinoma (PDAC). To assess the potential role of Np-1 in PDAC, COLO-357 pancreatic cancer cells, which express relatively low levels of Np-1, were stably transfected with the Np-1 cDNA. Np-1 overexpression was associated with enhanced cell invasiveness in response to hepatocyte growth factor (HGF), and this effect was abolished by small interfering RNA-mediated down-regulation of c-Met. Conversely, in PANC-1 pancreatic cancer cells, which express relatively high levels of Np-1, suppression of endogenous Np-1 completely abolished HGF-mediated cell invasion. To determine which pathways are involved in Np-1-mediated facilitation of c-Met-dependent cell invasiveness, the effects of HGF on signaling were examined next in sham-transfected and Np-1-overexpressing COLO-357 cells. HGF actions on c-Met tyrosine phosphorylation and p38 mitogen-activated protein kinase (MAPK) activation were increased in Np-1-overexpressing COLO-357 cells by comparison with HGF effects in sham-transfected cells. SB203580, an inhibitor of p38 MAPK, suppressed HGF-induced invasion in Np-1-overexpressing cells, whereas U0126, a MAP/extracellular signal-regulated kinase kinase inhibitor, was without effect. PP2, a Src inhibitor, and LY294002, a phosphatidylinositol 3-kinase inhibitor, also suppressed HGF-induced invasion in these cells. Immunoprecipitation studies revealed that Np-1 associated with c-Met, but not with epidermal growth factor receptor, family members. Confocal microscopy indicated that this association occurred on the plasma membrane and that HGF promoted the internalization of Np-1-c-Met complex, leading to its perinuclear localization. These findings indicate that Np-1 is required for efficient activation of c-Met-dependent pathways that promote cell invasiveness.
引用
收藏
页码:10309 / 10316
页数:8
相关论文
共 58 条
[1]   Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells [J].
Bauer, Todd W. ;
Somcio, Ray J. ;
Fan, Fan ;
Liu, Wenbiao ;
Johnson, Marjorie ;
Lesslie, Donald P. ;
Evans, Douglas B. ;
Gallick, Gary E. ;
Ellis, Lee M. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) :1676-1682
[2]   Characterization of Rac and Cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases [J].
Benard, V ;
Bohl, BP ;
Bokoch, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13198-13204
[3]   Tyrosine kinase signal specificity: lessons from the HGF receptor [J].
Bertotti, A ;
Comoglio, PM .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (10) :527-533
[4]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[5]   Dual specificity phosphatases: a gene family for control of MAP kinase function [J].
Camps, M ;
Nichols, A ;
Arkinstall, S .
FASEB JOURNAL, 2000, 14 (01) :6-16
[6]   Interplay between scatter factor receptors and B plexins controls invasive growth [J].
Conrotto, P ;
Corso, S ;
Gamberini, S ;
Comoglio, PM ;
Giordano, S .
ONCOGENE, 2004, 23 (30) :5131-5137
[7]  
DIRENZO MF, 1995, CANCER RES, V55, P1129
[8]  
EBERT M, 1994, CANCER RES, V54, P5775
[9]   Aberrant expression of neuropilin-1 and-2 in human pancreatic cancer cells [J].
Fukahi, K ;
Fukasawa, M ;
Neufeld, G ;
Itakura, J ;
Korc, M .
CLINICAL CANCER RESEARCH, 2004, 10 (02) :581-590
[10]  
FUKASAWA M, 2007, IN PRESS CANC BIOL T